Market revenue in 2023 | USD 606.9 million |
Market revenue in 2030 | USD 937.1 million |
Growth rate | 6.4% (CAGR from 2023 to 2030) |
Largest segment | In house |
Fastest growing segment | Contract Outsourcing |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | In House, Contract Outsourcing |
Key market players worldwide | Zoetis Inc Class A, SeQuent Scientific, Ofichem Group, The Chem-Pro Group, Siflon Drugs & Pharmaceuticals, Vetpharma, Suanfarma Biotech, Menadiona, Excel Industries |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to veterinary active pharmaceutical ingredients manufacturing market will help companies and investors design strategic landscapes.
In house was the largest segment with a revenue share of 61.89% in 2023. Horizon Databook has segmented the China veterinary active pharmaceutical ingredients manufacturing market based on in house, contract outsourcing covering the revenue growth of each sub-segment from 2018 to 2030.
The veterinary API manufacturing market in China is anticipated to witness significant growth over the forecast period. The prevalence of major outbreaks of animal diseases is expected to fuel the demand in the China veterinary API manufacturing market.
For instance, during the African Swine Fever outbreak, the livestock market, particularly the swine industry, faced substantial failures, resulting in significant deaths of pigs between 2 and 10 days after infection. This increased the need for effective treatments.
Since China’s food business majorly depends on animal products, extensive R&D is required to maintain the quality of feeds, pharmaceuticals, and vaccines. Hence, these aforementioned factors are anticipated to drive the market over the forecast period.
Horizon Databook provides a detailed overview of country-level data and insights on the China veterinary active pharmaceutical ingredients manufacturing market , including forecasts for subscribers. This country databook contains high-level insights into China veterinary active pharmaceutical ingredients manufacturing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account